{
    "organizations": [],
    "uuid": "1d78d340f26b95bcf66c1553dab4cddce8888803",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sartorius-stedim-biotech-2017-unde/brief-sartorius-stedim-biotech-2017-underlying-ebitda-up-by-2-2-idUSFWN1QA153",
    "ord_in_thread": 0,
    "title": "BRIEF-Sartorius Stedim Biotech 2017 Underlying EBITDA Up By 2.2%",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - SARTORIUS STEDIM BIOTECH SA:\n* SARTORIUS STEDIM BIOTECH TARGETS CONTINUED PROFITABLE GROWTH - SALES REVENUE PROJECTED AT AROUND 2.8 BILLION EUROS IN 2025\n* SALES REVENUE PROJECTED AT AROUND 2.8 BILLION EUROS IN 2025\n* NEW MEDIUM-TERM TARGETS: UNDERLYING EBITDA MARGIN OF ABOUT 30 PERCENT IN 2025\n* 2017 UNDERLYING EBITDA INCREASED BY 2.2% TO €294.9 MILLION‍​\n* 2017 INCREASE IN SALES REVENUE BY AROUND 4.1% TO EUR 1,081.0 MILLION\n* FORECASTS A RISE IN SALES REVENUE BY ABOUT 7% TO 10% IN 2018\n* SEES 2018 INCREASE OF UNDERLYING EBITDA MARGIN BY APPROX. 0.5 PERCENTAGE POINTS OVER PRIOR-YEAR FIGURE.\n* OUTLOOK 2018 CAPEX IS EXPECTED TO BE AT APPROX. 15% OF SALES Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-21T14:21:00.000+02:00",
    "crawled": "2018-02-22T17:44:47.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sartorius",
        "stedim",
        "biotech",
        "sa",
        "sartorius",
        "stedim",
        "biotech",
        "target",
        "continued",
        "profitable",
        "growth",
        "sale",
        "revenue",
        "projected",
        "around",
        "billion",
        "euro",
        "sale",
        "revenue",
        "projected",
        "around",
        "billion",
        "euro",
        "new",
        "target",
        "underlying",
        "ebitda",
        "margin",
        "percent",
        "underlying",
        "ebitda",
        "increased",
        "increase",
        "sale",
        "revenue",
        "around",
        "eur",
        "million",
        "forecast",
        "rise",
        "sale",
        "revenue",
        "see",
        "increase",
        "underlying",
        "ebitda",
        "margin",
        "approx",
        "percentage",
        "point",
        "figure",
        "outlook",
        "capex",
        "expected",
        "approx",
        "sale",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}